InvestorNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Featured on ‘PBA à Noon’ Podcast
July 29, 2021
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) was featured in a recent episode of the “PBA à Noon” podcast hosted by Paul Benwell & Associates. Avricore Health’s CEO Hector Bremner joined the program to discuss the company’s point-of-care testing platform, HealthTab(TM), which it recently launched in the first of 11 Shoppers Drug Mart pilot locations. The […]
InvestorNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTC: AVCRF) Partners with Ellerca Health to Provide Enhanced Diabetes Screening, Management Support
July 28, 2021
Avricore Health (TSX.V: AVCR) (OTC: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, has signed a partnership agreement with Ellerca Health Corp. The partnership is designed to leverage the two companies’ respective technologies and services in order to provide the most compelling diabetes screening and management solutions […]
InvestorNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) HealthTab(TM) Adds ID Now(TM) Molecular Test Device to Abbott Distribution Agreement
July 26, 2021
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced the signing of the first amendment to its supplier distribution agreement between HealthTab(TM) Inc., a wholly owned subsidiary, and Abbott, a global health care company and diagnostics leader in Canada. According to the update, the agreement, first signed on May 31, 2021, allows HealthTab(TM) to distribute in […]
Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Completes Successful Trial Rollout and Expansion of Pharmacy Diagnostic Network
Avricore Health is an innovator in pharmacy based point-of-care diagnostics The company introduced its flagship technology platform in an Ontario Shoppers Drug Mart pharmacy earlier this month as the lead-out to a 12-store rollout throughout the province Avricore’s trademarked HealthTab network is making diagnostic tools for diabetes and cardiovascular disease management accessible to patients and […]
InvestorNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Successful Beta Testing of HealthTab(TM)
July 19, 2021
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced that patient testing has begun on the first deployment of the new HealthTab(TM)-integrated Afinion 2(TM) analyzers in the initial Shoppers Drug Mart(R) pharmacy location. This move is part of the company’s previously announced effort to screen for diabetes and cardiovascular disease, demonstrating strong demand, smooth workflow and […]
Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Reports Successful Implementation and Testing of HealthTab(TM) in Shoppers Drug Mart(R) Locations
The program’s initial focus is to support those at risk or already diagnosed with diabetes or cardiovascular disease, offering better health management and quality of life In the United States, approximately 88 million adults live with prediabetes, and as many as 84% do not know they have it. It is estimated that by 2030, 13.6 […]
Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Is ‘One to Watch’
July 12, 2021
Avricore Health Inc. is a pharmacy solutions provider that combines best-in-class point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues The company’s wholly owned subsidiary, HealthTab, offers fast, accurate and cost-effective point-of-care screening Its current test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as […]